Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

M Xing, AS Alzahrani, KA Carson, D Viola, R Elisei… - Jama, 2013 - jamanetwork.com
Importance BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its
role in PTC-related patient mortality has not been established. Objective To investigate the …
被引用次数：1049 相关文章

[引用][C] Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

M Xing, AS Alzahrani, KA Carson, D Viola… - JAMA: the journal of …, 2013 - dialnet.unirioja.es
Resumen BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its
role in PTC-related patient mortality has not been established.
[HTML] nih.gov

[HTML][HTML] Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

M Xing, AS Alzahrani, MKA Carson… - JAMA: the journal of …, 2013 - ncbi.nlm.nih.gov
Results Overall, mortality was 5.3%(45/845; 95% CI, 3.9%–7.1%) vs 1.1%(11/1004; 95% CI,
0.5%–2.0%)(P<. 001) in BRAF V600E–positive vs mutation-negative patients. Deaths per …

[引用][C] Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.

M Xing, AS Alzahrani, KA Carson, D VIOLA, R ELISEI… - JAMA, 2013 - arpi.unipi.it

[引用][C] Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.

M Xing, A Alzahrani, K Carson, D Viola, R Elisei… - JAMA, 2013 - research.unipd.it
Design, Setting, and Participants Retrospective study of 1849 patients (1411 women and
438 men) with a median age of 46 years (interquartile range, 34-58 years) and an overall …

[引用][C] Association Between BRAFV600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

M XING, AS ALZAHRANI… - JAMA, the journal of …, 2013 - pascal-francis.inist.fr
Association Between BRAFV600E Mutation and Mortality in Patients With Papillary Thyroid
Cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

MM Xing, AS Alzahrani, KA Carson, D Viola, R Elisei… - JAMA, 2013 - pure.johnshopkins.edu
Abstract Importance: BRAF V600E is a prominent oncogene in papillary thyroid cancer
(PTC), but its role in PTC-related patient mortality has not been established. Objective: To …

Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer

J Czarniecka, S O'Neill, RE Lam, N Santisteban… - JAMA, 2013 - digital.csic.es
NIH Public Access Page 1 Association Between BRAF V600E Mutation and Mortality in
Patients With Papillary Thyroid Cancer Dr. Mingzhao Xing, MD, PhD, Dr. Ali S. Alzahrani, MD …

Association Between BRAFV6OOE Mutation and Mortality in Patients With Papillary Thyroid Cancer.

M Xing, AS Alzahrani, KA Carson… - JAMA: Journal of …, 2013 - search.ebscohost.com
The article discusses research which investigated the relationship between BRAF V600E
mutation and papillary thyroid cancer (PTC)-related mortality. BRAF V600E is a prominent …

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer

MM Xing, AS Alzahrani, KA Carson, D Viola, R Elisei… - JAMA, 2013 - air.unimi.it
Abstract Importance: BRAF V600E is a prominent oncogene in papillary thyroid cancer
(PTC), but its role in PTC-related patient mortality has not been established. Objective: To …